Ying Zhong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ying Zhong has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Hui Kang
Department of Laboratory Medicine, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, Guangdong, China
18 shared publications - Lihui Wang
Department of Pathology, School of Medicine, Jinan University, Guangzhou 510632, China
18 shared publications - Peiwen Li
Department of Pathology, School of Medicine Jinan University Guangzhou China
18 shared publications - Ziqing Ma
Department of Pathology, School of Medicine Jinan University Guangzhou China
18 shared publications - Zixi Qin
Department of Pathology, School of Medicine Jinan University Guangzhou China
18 shared publications - Jiayu Li
Department of Pathology, School of Medicine, Jinan University, Guangzhou, China
17 shared publications
Latest Publications
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
Correlation between VASN expression and the percentage of CD31+CD34+ / CD31+ blood vessels in clinical glioma tissues
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
Correlation between VASN expression and the percentage of CD31+CD34+ / CD31+ blood vessels in clinical glioma tissues
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
Establishment of glioma cell lines with VASN overexpressed or knocked down
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
Establishment of glioma cell lines with VASN overexpressed or knocked down
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Data from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
Glioma is a highly vascularized tumor of the central nervous system. Angiogenesis plays a predominant role in glioma progression and is considered an important therapeutic target. Our previous study showed that vasorin (VASN), a transmembrane protein, is overexpressed in glioma and promotes angiogenesis; however, the potential mechanism remains unclear. In this study, we found that human vascular endothelial cells (hEC) co-cultured with VASN-overexpressing glioma cells exhibited accelerated migration ability and increased expression of VASN originated from glioma cells. VASN was found in exosomes secreted by glioma cells and could be taken up by hECs. hECs showed more edge filopodia and significantly upregulated expression of endothelial tip cell marker gene and protein levels after co-culture with VASN-overexpressing glioma cells. In clinical glioma tissue and orthotopic transplantation glioma tissue, the vascular density and the number of vascular endothelial cells with a tip cell phenotype in VASN-overexpressed tissues were significantly higher than in tissues with low expression. At the molecular level, VASN interacted with VEGFR2 and caused internalization and autophosphorylation of VEGFR2 protein, and then activated the AKT signaling pathway. Our study collectively reveals the function and mechanism of VASN in facilitating angiogenesis in glioma, providing a new therapeutic target for glioma.Implications:These findings demonstrate that VASN exocytosed from glioma cells enhanced the migration of vascular endothelial cells by VEGFR2/AKT signaling pathway.
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
Glioma is a highly vascularized tumor of the central nervous system. Angiogenesis plays a predominant role in glioma progression and is considered an important therapeutic target. Our previous study showed that vasorin (VASN), a transmembrane protein, is overexpressed in glioma and promotes angiogenesis; however, the potential mechanism remains unclear. In this study, we found that human vascular endothelial cells (hEC) co-cultured with VASN-overexpressing glioma cells exhibited accelerated migration ability and increased expression of VASN originated from glioma cells. VASN was found in exosomes secreted by glioma cells and could be taken up by hECs. hECs showed more edge filopodia and significantly upregulated expression of endothelial tip cell marker gene and protein levels after co-culture with VASN-overexpressing glioma cells. In clinical glioma tissue and orthotopic transplantation glioma tissue, the vascular density and the number of vascular endothelial cells with a tip cell phenotype in VASN-overexpressed tissues were significantly higher than in tissues with low expression. At the molecular level, VASN interacted with VEGFR2 and caused internalization and autophosphorylation of VEGFR2 protein, and then activated the AKT signaling pathway. Our study collectively reveals the function and mechanism of VASN in facilitating angiogenesis in glioma, providing a new therapeutic target for glioma.Implications:These findings demonstrate that VASN exocytosed from glioma cells enhanced the migration of vascular endothelial cells by VEGFR2/AKT signaling pathway.
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
VASN knockdown inhibits HUVEC migration
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
VASN knockdown inhibits HUVEC migration
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
VASN induces tip cell phenotype transformation in HUVECs
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
VASN induces tip cell phenotype transformation in HUVECs
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
Immunofluorescence staining showing HUVECs uptake of Flag tag peptide
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
Immunofluorescence staining showing HUVECs uptake of Flag tag peptide
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
Correlation between VASN expression and the percentage of CD31+CD34+ / CD31+ blood vessels in clinical glioma tissues
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
Correlation between VASN expression and the percentage of CD31+CD34+ / CD31+ blood vessels in clinical glioma tissues
- Open Access
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
VASN induces tip cell phenotype transformation in HUVECs
- 2 July 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Vasorin Exocytosed from Glioma Cells Facilitates Angiogenesis via VEGFR2/AKT Signaling Pathway
VASN induces tip cell phenotype transformation in HUVECs